159 related articles for article (PubMed ID: 33003642)
1. G Protein-Coupled Receptor Genes, PTGDR1, PTGDR2, and PTGIR, Are Candidate Epigenetic Biomarkers and Predictors for Treated Patients with HPV-Associated Oropharyngeal Cancer.
Misawa K; Imai A; Kanazawa T; Mima M; Yamada S; Mochizuki D; Yamada T; Shinmura D; Ishikawa R; Kita J; Yamaguchi Y; Misawa Y; Mineta H
Microorganisms; 2020 Sep; 8(10):. PubMed ID: 33003642
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel methylation markers in HPV-associated oropharyngeal cancer: genome-wide discovery, tissue verification and validation testing in ctDNA.
Misawa K; Imai A; Matsui H; Kanai A; Misawa Y; Mochizuki D; Mima M; Yamada S; Kurokawa T; Nakagawa T; Mineta H
Oncogene; 2020 Jun; 39(24):4741-4755. PubMed ID: 32415241
[TBL] [Abstract][Full Text] [Related]
3. Prostanoid receptor genes confer poor prognosis in head and neck squamous cell carcinoma via epigenetic inactivation.
Misawa K; Mima M; Satoshi Y; Imai A; Mochizuki D; Ishikawa R; Kita J; Yamaguchi Y; Endo S; Misawa Y; Mineta H
J Transl Med; 2020 Jan; 18(1):31. PubMed ID: 31969157
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
5. Novel prognostic value and potential utility of opioid receptor gene methylation in liquid biopsy for oral cavity cancer.
Ishikawa R; Imai A; Mima M; Yamada S; Takeuchi K; Mochizuki D; Shinmura D; Kita JY; Nakagawa T; Kurokawa T; Misawa Y; Nakanishi H; Takizawa Y; Misawa K
Curr Probl Cancer; 2022 Apr; 46(2):100834. PubMed ID: 35042636
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
7. Circulating HPV DNA in the Management of Oropharyngeal and Cervical Cancers: Current Knowledge and Future Perspectives.
Krasniqi E; Barba M; Venuti A; Pizzuti L; Cappuzzo F; Landi L; Carpano S; Marchetti P; Villa A; Vizza E; Giuliano G; Mazzotta M; Marinelli D; Gnignera S; Vincenzoni C; Stranges V; Sergi D; Giordano A; Tomao F; Maugeri-Saccà M; Sanguineti G; Di Lisa FS; Tomao S; Ciliberto G; Vici P
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917435
[TBL] [Abstract][Full Text] [Related]
8. Methylation of HPV16 and EPB41L3 in oral gargles and the detection of early and late oropharyngeal cancer.
Dickey BL; Nedjai B; Preece MD; Schell MJ; Boulware D; Whiting J; Sirak B; Abrahamsen M; Isaacs-Soriano KA; Kennedy K; Chung CH; Giuliano AR
Cancer Med; 2022 Oct; 11(20):3735-3742. PubMed ID: 35619332
[TBL] [Abstract][Full Text] [Related]
9. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
[TBL] [Abstract][Full Text] [Related]
10. Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer.
Kano M; Kondo S; Wakisaka N; Wakae K; Aga M; Moriyama-Kita M; Ishikawa K; Ueno T; Nakanishi Y; Hatano M; Endo K; Sugimoto H; Kitamura K; Muramatsu M; Yoshizaki T
Int J Cancer; 2019 Sep; 145(6):1547-1557. PubMed ID: 31228270
[TBL] [Abstract][Full Text] [Related]
11. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
[TBL] [Abstract][Full Text] [Related]
12. The Use of HPV16-E5, EGFR, and pEGFR as Prognostic Biomarkers for Oropharyngeal Cancer Patients.
Taberna M; Torres M; Alejo M; Mena M; Tous S; Marquez S; Pavón MA; León X; García J; Guix M; Hijano R; Bonfill T; Aguilà A; Lozano A; Mesía R; Alemany L; Bravo IG
Front Oncol; 2018; 8():589. PubMed ID: 30619735
[No Abstract] [Full Text] [Related]
13. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
[TBL] [Abstract][Full Text] [Related]
14. Double positivity for HPV-DNA/p16
Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L
Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus circulating tumor DNA assays as a mechanism for head and neck cancer equity in rural regions of the United States.
Windon M; Haring C
Front Oncol; 2024; 14():1373905. PubMed ID: 38779091
[TBL] [Abstract][Full Text] [Related]
16. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Biomarker Panel from Genome-Wide Methylation to Detect Early HPV-Associated Oropharyngeal Cancer.
Dickey BL; Putney RM; Schell MJ; Berglund AE; Amelio AL; Caudell JJ; Chung CH; Giuliano AR
Cancer Prev Res (Phila); 2024 Apr; 17(4):169-176. PubMed ID: 38286404
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
[TBL] [Abstract][Full Text] [Related]
19. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
